By Trendlyne AnalysisThis financial services company gained around 3% on Thursday after announcing its entry into the gold-loan business. It plans to open more than 200 dedicated branches by the end of FY27 and scale the network to around 1,000 branches over the next three years, expanding its presence across urban and semi-urban markets.
Gold loans are emerging as one of the fastest-growing retail credit segments, with NBFC (non-banking financial company) lending against gold jewellery rising 69% YoY in June 2026. Higher gold prices have also boosted the value of jewellery that borrowers can pledge, supporting demand for gold-backed loans. The new business will add a secured retail product to the company’s lending portfolio. Still, execution remains a key monitorable as it takes on established players such as Muthoot Finance and Manappuram Finance.
The expansion comes as its existing lending businesses continue to grow. Q1 performance beat Forecaster estimates, with revenue rising 29% and net profit jumping 40%. The overall lending portfolio grew 32%, driven by strong growth in both the NBFC and housing-finance (HF) businesses. Asset quality remained stable, with provisions for bad loans edging down from a year earlier.
Housing finance is emerging as a growth driver, as profit before tax from the segment doubled after asset under management (AUM) rose 50%. HF CEO Pankaj Gadgil said the business is “looking at moving (to double) the AUM close to 1 lakh crores in the next 6 to 8 quarters.” To achieve this, the firm plans to add around 200 branches this fiscal year, while keeping operating costs broadly range-bound despite continued investments in the network.
Aditya Birla Capital also raised Rs 4,000 crore in fresh capital during Q1, with 87.5% allocated for growth in its NBFC business. Management said the capital should support the NBFC’s growth requirements over the next three years, providing funding headroom as it expands into gold loans and other retail products.
Motilal Oswal reiterated its ‘Buy’ rating with a target price of Rs 480. The brokerage expects the company’s expanding customer base and broader product suite to drive cross-selling, with consolidated profit projected to grow at around 28% annually over FY27-28.
This pharmaceutical company rose 6% on Tuesday after it won approval under the Electronics Components Manufacturing Scheme for its Electrolyte Additives manufacturing business. Acutaas is investing Rs 256.5 crore in the project and could receive up to Rs 30 crore in government incentives.
Electrolyte additives are chemicals used in batteries to improve their performance and stability. The company has begun commercial supplies of two such products from its new 4,000-tonne plant. It is also adding another electrolyte additive, which already has a signed customer contract and is expected to ramp up in FY28.
In Q1FY27, revenue rose 59% YoY to Rs 329.7 crore, led by a 77% jump in advanced pharmaceutical intermediates revenue. Growth was driven by higher sales of existing and newer pharmaceutical intermediates and its contract development and manufacturing (CDMO) business. Net profit surged 70%, helped by a better product mix and operating efficiencies.
The company is targeting Rs 1,000 crore in CDMO revenue by FY28. President of Strategy Abhishek Patel said, “We expect four new CDMO products to start contributing revenue from the second half of this year. Each has a peak annual revenue potential of Rs 50-100 crore.”
Specialty chemicals revenue, however, fell 10.6% as the company phased out lower-margin commodity chemicals. Management expects growth in semiconductor chemicals, battery chemicals and newer specialty products to more than offset the decline in commodity chemicals this year. Acutaas is also expanding its semiconductor chemicals business through Indichem, its South Korean joint venture. Construction of the plant is ahead of schedule, with revenue expected from the next financial year.
Following Q1 results, Deven Choksey maintained its 'Accumulate' rating on the stock with a higher target price of Rs 3,567. The brokerage expects contract manufacturing, battery and semiconductor chemicals to support growth as the company moves towards higher-value products. It expects net profit to grow at a CAGR of 28% through FY28.
Thishome-textile company gained 18% over the past week after announcing itsQ1FY27 results on August 13. Revenue rose 24% YoY, beatingForecaster estimates by 4%, while net profit jumped 84%. Higher sales volume and a more profitable product mix drove this growth.
The US accounts for ~60% of Welspun’s revenue, with the pillow business emerging as a major growth driver. Revenue of the pillow business more than doubled in Q1 as capacity utilisation at the company’s Ohio factory reached ~81% and its Nevada plant began operations. Management expects pillow revenue to double to around $60 million in FY27.
Profitability is also improving in the flooring business, where EBITDA margin reached 10.4%, its highest in over two years. Management attributed the improvement to higher sales of soft flooring products, expansion into new markets, and tighter cost control. To support higher volumes, Welspun is also upgrading its existing plants. CFO Manish Bansalsaid, “We are targeting roughly around Rs 400 crore to Rs 500 crore of capex. And that is for automation, modernisation, and debottlenecking.”
The UK has become another potential growth market after the India-UK free trade agreement took effect in July. They import an estimated $5–7 billion of home textiles annually. The deal puts India on equal tariff terms with Pakistan, which supplies over half of the UK’s home-textile imports. Welspun already has retailer relationships in the UK and an established presence through Christy, its premium home textiles brand, helping it pursue new orders without building a distribution network from scratch.
A key near-term challenge is flooding at its Vapi facility, which management expects to affect Q2. However, production partially resumed within a week, with output rerouted to other plants. MD & CEO Dipali Goenkasaid, “I can tell you that in Q3 and Q4, we are going to restore growth. So, for the full year, Welspun Living will continue to deliver double-digit growth.”
Post results, Motilal Oswalmaintained its ‘Buy’ rating with a target price of Rs 215. The brokerage expects Welspun’s emerging businesses to contribute more over the next two years, alongside the recovery in its core home-textile business. It also raised its FY27 and FY28 earnings estimates on better growth visibility.
This telecom services company rose 1.6% over the past week after reporting its June-quarter results. Q1FY27 revenue rose 11.8% YoY, driven by growth in the mobile services segment. Meanwhile, net profit rose 23.2%, supported by higher average revenue per user (ARPU) and an improving premium subscriber mix. However, net profit came in 15.7% below Trendlyne’s Forecaster estimates due to softer subscriber additions during the quarter. The stock features in a screener of companies that have shown relative outperformance compared with their industry over the past month.
New smartphone data subscriber additions slowed to 3.4 lakh in Q1, down from roughly 5 lakh in the previous quarter. Management explained this as typical seasonal behaviour, noting that customer sign-ups usually dip in the first half of the year before picking up speed in the second half.
Accounting for roughly 8% of its parent Airtel’s total subscriber base and regional footprint, Bharti Hexacom benefited directly from Airtel’s strategy of phasing out budget prepaid plans and nudging users toward premium tiers. This strategic shift helped drive its ARPU up to Rs 259, compared to Rs 246 in Q1FY26. While management noted that an extra calendar day in the quarter provided a minor tailwind, top-line growth was fueled by heavy data consumption, structural upgrades, and widespread adoption of premium plans.
In a notable milestone, Bharti Hexacom’s data engagement surpassed that of Airtel. Its subscribers used an average of 36.2 GB of data per month, exceeding Airtel’s national average of 34.4 GB. Management noted that it remains focused on 5G densification and scaling the Homes & Offices Service business.
Motilal Oswal retained its ‘Buy’ rating on the stock and raised its target price to Rs 2,050. The brokerage projects customer revenue and EBITDA to grow at CAGRs of ~14% and ~18%, respectively, over FY27-29, driven by an expected ~15% tariff hike in Q3FY27, led by continued premiumisation and market share gains.
This consumer electricals company rose 2.7% on Thursday after laying out its long-term growth plans at its Investor Day. Crompton aims to double revenue over the next four years, with new businesses such as solar pumps, rooftop solar and wires expected to play a bigger role. These categories currently contribute little to revenue but could eventually grow to account for around 20% of sales.
The core business is also moving towards higher-value products. In Q1FY27, revenue rose 12% YoY, and profit increased 15%, despite supply disruptions and commodity inflation. Its electrical consumer durables business grew 11%, led by sales of premium BLDC fans. CFO Kaleeswaran Arunachalam said, “The BLDC journey for us is probably beginning,” adding that there is a “long, long leg room” for growth.
Solar rooftop could become one of the more immediate contributors from the newer businesses. Crompton has built an order book of around Rs 500 crore within four months of entering the business. Commenting on execution, MD & CEO Promeet Ghosh said, “This quarter and the next quarter are where I would expect a huge bulk of that order book to get executed.” With around 80% of the market still unorganised, the company is betting that its existing brand, distribution and service network can help it gain share.
However, execution will depend partly on how well Crompton manages supply chains and raw material costs. The company lost around Rs 200 crore in primary sales in Q1 due to supply disruptions, although management said most of the issues had stabilised by June-end and had returned to normal in July. To offset higher input costs, the firm used price hikes alongside its cost-management programme. Management said around 80% of inflationary costs had already been passed on, while cost savings and operating leverage helped improve EBITDA margin by 20 bps.
Motilal Oswal maintains a ‘Buy’ rating with a target price of Rs 340. It expects revenue and net profit to grow at 13% and 21% annually over FY27–28. The brokerage also expects Crompton’s strong free cash flow to support expansion without adding pressure on its balance sheet.
Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.